Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
about
Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Pharmacogenomics and cardiovascular diseaseImpact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysisWarfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.Exploring genetic associations with ceRNA regulation in the human genome.Cardiovascular pharmacogenomicsCorrelation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients.Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisGenetic determinants of response to cardiovascular drugs.Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Methodological issues in the development of a pharmacogenomic algorithm for warfarin dosing: comparison of two regression approaches.Correlation between Rs2108622 Locus of CYP4F2 Gene Single Nucleotide Polymorphism and Warfarin Dosage in Iranian Cardiovascular Patients.
P2860
Q26823542-84FA2732-3C85-4905-B685-B30A0705F7F2Q26997380-414891BA-F6F7-4412-919D-C836F7A4F90CQ28071310-EC64E9B1-7C0E-4ABC-928F-11BF86C83684Q31131437-42C3D552-94B2-473D-9968-77C81E313E86Q33741112-CB31158E-563E-49AC-8C0C-6A853A34C45FQ35447163-65106335-6B1C-4149-992F-21351C246A60Q36368040-14D6F9EC-91AB-4702-9268-8C3A7E4C3FE7Q37065161-5B32EB16-DDCF-4F16-A4C4-93F94DD9E80CQ37989811-47134BA3-EEFC-4C09-A29F-C6DF97E2C8D0Q42705932-4A41518E-D739-4B08-A1C5-1EFE58223963Q43879115-83B74F54-D9E7-4EE5-973D-17C44E48A31DQ45362158-CEBB4CBC-3E26-4584-9DE5-3BD92625DF38Q49892570-35E270CB-C700-4B4E-B9E6-96E4F962FD5C
P2860
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@ast
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en-gb
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@nl
type
label
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@ast
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en-gb
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@nl
prefLabel
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@ast
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en-gb
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@nl
P2093
P2860
P921
P3181
P356
P1476
Genetic variation of VKORC1 an ...... nts with myocardial infarction
@en
P2093
Armin P Piehler
Camilla Stormo
Ingebjørg Seljeflot
Kari Bente Foss Haug
Marianne K Kringen
Mimi S Opdal
Per W Johansen
Runa M Grimholt
Sigrid Narum
P2860
P304
P3181
P356
10.1155/2011/739751
P407
P577
2010-11-24T00:00:00Z